Boston-based Moderna has been the S&P 500’s most shorted stock since the end of September, according to S3 Partners. Short ...

President Trump is expected to unveil plans to lower healthcare costs, which could significantly impact the pharmaceutical industry. Additionally, Pfizer's (PFE) entry into the weight-loss drug space, ...

Moderna’s stock has seen a notable shift in sentiment after its fair value estimate was cut from $40.30 to $37.32. This ...

Moderna ( ($MRNA) ) just unveiled an update. On November 19, 2025, Moderna, Inc. entered into a Credit and Guaranty Agreement providing a $1.5 ...

The Dow Jones Industrial Average edged down 0.8% to 45,752.26, while the S&P 500 dropped 1.56% to 6,538.76 and the Nasdaq ...

According to TipRanks.com, Schmidt is a 5-star analyst with an average return of 24.6% and a 57.3% success rate. Schmidt covers the Healthcare sector, focusing on stocks such as Monte Rosa ...

On November 20, 2025, Moderna, Inc. announced updates on its pipeline progress and business strategy during its Analyst Day. This announcement is significant as it reflects the company’s ongoing ...

Take Vertex Pharmaceuticals (NASDAQ: VRTX), for example. In late 2020, the big biotech company's approved products focused on ...

In this week’s edition of InnovationRx, we look at the RFK Jr.’s war on vaccines, Abbott’s $21 billion bet on cancer ...

The Dow Jones Industrial Average added 248 points, and the S&P 500 index gained over 30 points. The tech-heavy Nasdaq ...

Pfizer Canada says it has placed temporary limits on orders of one of its COVID shots at community pharmacies, found outside ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...